Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 1
2013 1
2018 2
2019 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.
Einsele H, Briones J, Ciceri F, García Cadenas I, Falkenburg F, Bolaños N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris EC, O'Dwyer M, Sierra JG, van den Brink M, van de Loosdrecht AA. Einsele H, et al. Among authors: falkenburg f. Hemasphere. 2021 Sep 10;5(10):e642. doi: 10.1097/HS9.0000000000000642. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34522844 Free PMC article.
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies.
Einsele H, Briones J, Ciceri F, García-Cadenas I, Falkenburg F, Bolaños N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris CE, O'Dwyer M, Gil JS, van den Brink M, van de Loosdrecht AA. Einsele H, et al. Among authors: falkenburg f. Hemasphere. 2020 Jun 29;4(4):e423. doi: 10.1097/HS9.0000000000000423. eCollection 2020 Aug. Hemasphere. 2020. PMID: 32904089 Free PMC article. No abstract available.
Towards a cancer mission in Horizon Europe: recommendations.
Berns A, Ringborg U, Celis JE, Heitor M, Aaronson NK, Abou-Zeid N, Adami HO, Apostolidis K, Baumann M, Bardelli A, Bernards R, Brandberg Y, Caldas C, Calvo F, Dive C, Eggert A, Eggermont A, Espina C, Falkenburg F, Foucaud J, Hanahan D, Helbig U, Jönsson B, Kalager M, Karjalainen S, Kásler M, Kearns P, Kärre K, Lacombe D, de Lorenzo F, Meunier F, Nettekoven G, Oberst S, Nagy P, Philip T, Price R, Schüz J, Solary E, Strang P, Tabernero J, Voest E. Berns A, et al. Among authors: falkenburg f. Mol Oncol. 2020 Aug;14(8):1589-1615. doi: 10.1002/1878-0261.12763. Mol Oncol. 2020. PMID: 32749074 Free PMC article.
The EBMT activity survey: 1990-2010.
Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; European Group for Blood and Marrow Transplantation (EBMT). Passweg JR, et al. Among authors: falkenburg f. Bone Marrow Transplant. 2012 Jul;47(7):906-23. doi: 10.1038/bmt.2012.66. Epub 2012 Apr 30. Bone Marrow Transplant. 2012. PMID: 22543746
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
Verkaik NJ, Hoek RA, van Bergeijk H, van Hal PT, Schipper ME, Pas SD, Beersma MF, Boucher CA, Jedema I, Falkenburg F, Hoogsteden HC, van den Blink B, Murk JL. Verkaik NJ, et al. Among authors: falkenburg f. Transpl Infect Dis. 2013 Dec;15(6):E243-9. doi: 10.1111/tid.12156. Epub 2013 Oct 23. Transpl Infect Dis. 2013. PMID: 24298985 Review.
Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation.
Marijt E, Wafelman A, van der Hoorn M, van Bergen C, Bongaerts R, van Luxemburg-Heijs S, van den Muijsenberg J, Wolbers JO, van der Werff N, Willemze R, Falkenburg F. Marijt E, et al. Among authors: falkenburg f. Haematologica. 2007 Jan;92(1):72-80. doi: 10.3324/haematol.10433. Haematologica. 2007. PMID: 17229638 Free article. Clinical Trial.